NasdaqCM - Delayed Quote • USD
Applied DNA Sciences, Inc. (APDN)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 7:51 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.22 | -0.18 | -0.65 | -0.53 |
| Low Estimate | -0.23 | -0.2 | -0.67 | -0.58 |
| High Estimate | -0.22 | -0.17 | -0.63 | -0.48 |
| Year Ago EPS | 0.05 | -0.24 | -0.76 | -0.65 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 950k | 1.18M | 5.02M | 8.17M |
| Low Estimate | 900k | 950k | 3.94M | 7.05M |
| High Estimate | 1M | 1.41M | 6.1M | 9.29M |
| Year Ago Sales | -- | -- | 13.37M | 5.02M |
| Sales Growth (year/est) | -- | -- | -62.40% | 62.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.2 | -0.24 | -0.27 | -0.31 |
| EPS Actual | 0.05 | -0.24 | -0.26 | -0.09 |
| Difference | 0.25 | 0 | 0.01 | 0.22 |
| Surprise % | 125.00% | 0.00% | 3.70% | 71.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.22 | -0.18 | -0.65 | -0.53 |
| 7 Days Ago | -0.22 | -0.18 | -0.65 | -0.53 |
| 30 Days Ago | -0.22 | -0.18 | -0.65 | -0.53 |
| 60 Days Ago | -0.22 | -0.18 | -0.65 | -0.53 |
| 90 Days Ago | -0.22 | -0.16 | -0.83 | -0.57 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | APDN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -540.00% | -- | -- | 0.80% |
| Next Qtr. | 25.00% | -- | -- | 9.60% |
| Current Year | 14.50% | -- | -- | 4.50% |
| Next Year | 18.50% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/9/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 12/8/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/24/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/14/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/12/2023 |
Related Tickers
ISPC iSpecimen Inc.
0.4210
+97.65%
GENE Genetic Technologies Limited
2.4400
-22.78%
OLK Olink Holding AB (publ)
22.27
-0.09%
ACRS Aclaris Therapeutics, Inc.
1.2300
0.00%
CHEK Check-Cap Ltd.
2.2600
+3.67%
CNTG Centogene N.V.
0.4610
-2.12%
BIOPOR.CO BioPorto A/S
1.2540
-1.57%
PRPO Precipio, Inc.
6.71
-0.96%
CDNA CareDx, Inc
8.07
-2.54%
RVTY Revvity, Inc.
99.38
-1.09%